Surgical Revascularization Outcomes After Oral Anticoagulation or Antiplatelets

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT03605433

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Unidade Local de Saúde de Coimbra, EPE (from the registry)
Registry
  • NCT NCT03605433
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Portugal (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03605433. Non-randomized; no masking; primary purpose treatment. Start 2018-12-01 (anticipated); primary completion 2019-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Surgical Revascularization Outcomes After Oral Anticoagulation or Antiplatelets
Acronym
SCOOP
Condition
Saphenous Vein Graft Patency
Intervention (Drug)
Rivaroxaban
Lead sponsor
Unidade Local de Saúde de Coimbra, EPE (class: other)

Record details

Record id
cardio:ct-nct03605433
Content hash
1e610da1b1bd350c91d95399d8f2a67ec1d85e9872a8a29a90476ee0b20058a2